Lexpos News

/Lexpos News

UKHSA launches new AMR awareness campaign

The UK Health Security Agency (UKHSA) has launched a new campaign to help increase awareness of antimicrobial resistance (AMR). Targeted at younger adults, the campaign aims to build support for the behaviours that will help keep antibiotics working. Over the course of six weeks, the character ‘Andi Biotic’ will be popping up to make sure [...]

The post UKHSA launches new AMR awareness campaign appeared first on Community Pharmacy England.

By |April 8th, 2025|Lexpos News|Comments Off on UKHSA launches new AMR awareness campaign

Medicine Supply Notification: Triamcinolone acetonide 10mg/ml (Adcortyl® ampoules) and 40mg/ml (Kenalog® vials) suspension for injection

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Triamcinolone acetonide 10mg/ml (Adcortyl® ampoules) and 40mg/ml (Kenalog® vials) suspension for injection. MSN/2025/021 Tier 2 – medium impact Date of issue: 7th April 2025 Triamcinolone acetonide 10mg/ml (Adcortyl® ampoules) and 40mg/ml (Kenalog® vials) suspension for injection are being discontinued with stock [...]

The post Medicine Supply Notification: Triamcinolone acetonide 10mg/ml (Adcortyl® ampoules) and 40mg/ml (Kenalog® vials) suspension for injection appeared first on Community Pharmacy England.

By |April 7th, 2025|Lexpos News|Comments Off on Medicine Supply Notification: Triamcinolone acetonide 10mg/ml (Adcortyl® ampoules) and 40mg/ml (Kenalog® vials) suspension for injection

Medicine Supply Notification: Triamcinolone acetonide 10mg/ml (Adcortyl® ampoules) and 40mg/ml (Kenalog® vials) suspension for injection

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Triamcinolone acetonide 10mg/ml (Adcortyl® ampoules) and 40mg/ml (Kenalog® vials) suspension for injection. MSN/2025/021 Tier 2 – medium impact Date of issue: 7th April 2025 Triamcinolone acetonide 10mg/ml (Adcortyl® ampoules) and 40mg/ml (Kenalog® vials) suspension for injection are being discontinued with stock [...]

The post Medicine Supply Notification: Triamcinolone acetonide 10mg/ml (Adcortyl® ampoules) and 40mg/ml (Kenalog® vials) suspension for injection appeared first on Community Pharmacy England.

By |April 7th, 2025|Lexpos News|Comments Off on Medicine Supply Notification: Triamcinolone acetonide 10mg/ml (Adcortyl® ampoules) and 40mg/ml (Kenalog® vials) suspension for injection

Medicine Supply Notification: Triamcinolone acetonide 10mg/ml (Adcortyl® ampoules) and 40mg/ml (Kenalog® vials) suspension for injection

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Triamcinolone acetonide 10mg/ml (Adcortyl® ampoules) and 40mg/ml (Kenalog® vials) suspension for injection. MSN/2025/021 Tier 2 – medium impact Date of issue: 7th April 2025 Triamcinolone acetonide 10mg/ml (Adcortyl® ampoules) and 40mg/ml (Kenalog® vials) suspension for injection are being discontinued with stock [...]

The post Medicine Supply Notification: Triamcinolone acetonide 10mg/ml (Adcortyl® ampoules) and 40mg/ml (Kenalog® vials) suspension for injection appeared first on Community Pharmacy England.

By |April 7th, 2025|Lexpos News|Comments Off on Medicine Supply Notification: Triamcinolone acetonide 10mg/ml (Adcortyl® ampoules) and 40mg/ml (Kenalog® vials) suspension for injection

MHRA Class 4 Medicines Notification: Renacet 475 mg and 950 mg tablets (RenaCare NephroMed GmbH)

MHRA Class 4 Medicines Notification: Renacet 475 mg and 950 mg tablets (RenaCare NephroMed GmbH) Date issued: 7 April 2025 Cross Healthcare Limited has informed the MHRA that there is a printing defect on the outer labels for the Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension. DMRC reference number: DMRC-35184448 Company name: [...]

The post MHRA Class 4 Medicines Notification: Renacet 475 mg and 950 mg tablets (RenaCare NephroMed GmbH) appeared first on Community Pharmacy England.

By |April 7th, 2025|Lexpos News|Comments Off on MHRA Class 4 Medicines Notification: Renacet 475 mg and 950 mg tablets (RenaCare NephroMed GmbH)